Excess TPX2 Interferes with Microtubule Disassembly and Nuclei Reformation at Mitotic Exit.
Aurora Kinase A
/ metabolism
Cell Cycle Proteins
/ metabolism
Cell Line
Cell Nucleus
/ metabolism
Chromatin
/ metabolism
Cytoskeleton
/ metabolism
Golgi Apparatus
/ metabolism
Humans
Lamin Type B
/ metabolism
Metaphase
Microtubule-Associated Proteins
/ metabolism
Microtubules
/ metabolism
Mitosis
Protein Binding
Telophase
TPX2
mitosis
nuclear envelope
spindle
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
06 02 2020
06 02 2020
Historique:
received:
20
12
2019
revised:
24
01
2020
accepted:
29
01
2020
entrez:
12
2
2020
pubmed:
12
2
2020
medline:
11
2
2021
Statut:
epublish
Résumé
The microtubule-associated protein TPX2 is a key mitotic regulator that contributes through distinct pathways to spindle assembly. A well-characterised function of TPX2 is the activation, stabilisation and spindle localisation of the Aurora-A kinase. High levels of TPX2 are reported in tumours and the effects of its overexpression have been investigated in cancer cell lines, while little is known in non-transformed cells. Here we studied TPX2 overexpression in hTERT RPE-1 cells, using either the full length TPX2 or a truncated form unable to bind Aurora-A, to identify effects that are dependent-or independent-on its interaction with the kinase. We observe significant defects in mitotic spindle assembly and progression through mitosis that are more severe when overexpressed TPX2 is able to interact with Aurora-A. Furthermore, we describe a peculiar, and Aurora-A-interaction-independent, phenotype in telophase cells, with aberrantly stable microtubules interfering with nuclear reconstitution and the assembly of a continuous lamin B1 network, resulting in daughter cells displaying doughnut-shaped nuclei. Our results using non-transformed cells thus reveal a previously uncharacterised consequence of abnormally high TPX2 levels on the correct microtubule cytoskeleton remodelling and G1 nuclei reformation, at the mitosis-to-interphase transition.
Identifiants
pubmed: 32041138
pii: cells9020374
doi: 10.3390/cells9020374
pmc: PMC7072206
pii:
doi:
Substances chimiques
Cell Cycle Proteins
0
Chromatin
0
Lamin Type B
0
Microtubule-Associated Proteins
0
TPX2 protein, human
0
Aurora Kinase A
EC 2.7.11.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/R004137/1
Pays : United Kingdom
Références
Nature. 2019 Dec;576(7785):158-162
pubmed: 31776509
J Cell Sci. 2019 May 16;132(10):
pubmed: 31028180
Elife. 2020 Jan 14;9:
pubmed: 31933480
J Mol Biol. 2016 May 22;428(10 Pt A):1962-85
pubmed: 26423234
J Cell Sci. 2004 Dec 15;117(Pt 26):6511-22
pubmed: 15572412
EMBO J. 2003 May 1;22(9):2060-70
pubmed: 12727873
Cell. 2001 Jan 12;104(1):83-93
pubmed: 11163242
Chromosoma. 1998 Dec;107(6-7):479-85
pubmed: 9914380
Open Biol. 2013 Sep 04;3(9):130097
pubmed: 24004664
Cancer Res. 2012 Mar 15;72(6):1518-28
pubmed: 22266221
Cell Mol Life Sci. 2014 Aug;71(16):3027-47
pubmed: 24556998
Curr Biol. 2002 Dec 10;12(23):2055-9
pubmed: 12477396
Science. 2016 Apr 15;352(6283):353-8
pubmed: 27013428
Nucleus. 2014 Jan-Feb;5(1):40-6
pubmed: 24637392
Elife. 2017 Nov 09;6:
pubmed: 29120325
Biochim Biophys Acta. 2010 Dec;1806(2):230-9
pubmed: 20708655
J Cell Sci. 2016 Apr 1;129(7):1319-28
pubmed: 26869224
Mol Cell Biol. 2015 Mar;35(5):884-98
pubmed: 25535332
Chromosoma. 2016 Sep;125(4):607-19
pubmed: 26728621
Methods Appl Fluoresc. 2015 Jan 16;3(1):014002
pubmed: 29148478
Curr Opin Cell Biol. 2015 Aug;35:78-90
pubmed: 25982429
Carcinogenesis. 2007 May;28(5):899-912
pubmed: 17259655
Dev Biol. 2014 Jul 1;391(1):81-8
pubmed: 24709321
J Cell Biol. 1998 Nov 2;143(3):673-85
pubmed: 9813089
Front Oncol. 2015 Dec 21;5:290
pubmed: 26734572
Mol Cell. 2003 Oct;12(4):851-62
pubmed: 14580337
Nat Cell Biol. 2015 Nov;17(11):1422-34
pubmed: 26414402
J Cell Biol. 2008 Jul 14;182(1):77-88
pubmed: 18606852
Cell Cycle. 2013 Apr 1;12(7):1030-41
pubmed: 23428904
Biol Cell. 2017 Oct;109(10):364-374
pubmed: 28799169
J Cell Biol. 2003 Jan 6;160(1):25-39
pubmed: 12515822
Sci Signal. 2018 Aug 14;11(543):
pubmed: 30108183
J Opt Soc Am A Opt Image Sci Vis. 2016 Jul 1;33(7):B12-20
pubmed: 27409703
Nat Rev Mol Cell Biol. 2017 Mar;18(3):187-201
pubmed: 28174430
J Cell Sci. 1993 May;105 ( Pt 1):145-56
pubmed: 8360269
Nat Cell Biol. 2015 Jul;17(7):907-16
pubmed: 26098575
Oncogenesis. 2019 Apr 15;8(5):29
pubmed: 30988276
Dev Cell. 2018 Dec 3;47(5):547-563.e6
pubmed: 30513301
Science. 2016 Apr 15;352(6283):359-62
pubmed: 27013426
J Cell Biol. 2008 Jul 28;182(2):289-300
pubmed: 18663142
EMBO Rep. 2018 Aug;19(8):
pubmed: 29925526
J Cell Biol. 2006 Jun 5;173(5):685-94
pubmed: 16735579
Cell. 2013 Feb 14;152(4):768-77
pubmed: 23415226
Oncogene. 2019 Feb;38(6):852-867
pubmed: 30177840
Nat Genet. 2006 Sep;38(9):1043-8
pubmed: 16921376
J Cell Sci. 2011 Jan 1;124(Pt 1):113-22
pubmed: 21147853
Appl Opt. 2006 Jul 10;45(20):5037-45
pubmed: 16807615
J Cell Biol. 2011 Oct 3;195(1):87-98
pubmed: 21969468
Cell. 2017 May 18;169(5):780-791
pubmed: 28525751
Curr Biol. 2018 Jan 8;28(1):121-129.e4
pubmed: 29276125
Nat Cell Biol. 2002 Nov;4(11):871-9
pubmed: 12389033
Chemphyschem. 2014 Mar 17;15(4):794-800
pubmed: 24436314
J Cell Sci. 2012 Jan 1;125(Pt 1):133-43
pubmed: 22250201
J Cell Biol. 2003 Apr 28;161(2):281-94
pubmed: 12707311
J Cell Biol. 2017 Apr 3;216(4):983-997
pubmed: 28264915
Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):4997-5002
pubmed: 21383178
Cell Cycle. 2006 Feb;5(3):296-303
pubmed: 16418575
J Cell Biol. 2002 Aug 19;158(4):617-23
pubmed: 12177045
Mol Cell Biol. 2005 Dec;25(23):10516-27
pubmed: 16287863
Genes Chromosomes Cancer. 2012 Jun;51(6):545-56
pubmed: 22337647
Nature. 2015 Jun 11;522(7555):231-5
pubmed: 26040712
Biochem J. 2018 Jun 26;475(12):2025-2042
pubmed: 29946042
Mol Cell. 2014 Aug 21;55(4):578-91
pubmed: 25042804
Genes Cancer. 2012 Nov;3(11-12):721-30
pubmed: 23634259